BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| arabinogalactan {arabinogalactan} - Roseburia |
📓
Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice. PloS one (PLoS One ) Vol: 6 Issue 6 Pages: e20944 Pub: 2011 Epub: 2011 Jun 9 Authors Neyrinck AM , Possemiers S , Druart C , Van de Wiele T , De Backer F , Cani PD , Larondelle Y , Delzenne NM , Html Article Publication |
| arabinogalactan {arabinogalactan} - Roseburia |
📓
The Gut Microbiota from Lean and Obese Subjects Contribute Differently to the Fermentation of Arabinogalactan and Inulin. PloS one (PLoS One ) Vol: 11 Issue 7 Pages: e0159236 Pub: 2016 Epub: 2016 Jul 13 Authors Aguirre M , Bussolo de Souza C , Venema K , Html Article Publication |
| arabinogalactan {arabinogalactan} - Roseburia |
📓
The role of short-chain fatty acids in microbiota-gut-brain communication. Nature reviews. Gastroenterology & hepatology (Nat Rev Gastroenterol Hepatol ) Vol: 16 Issue 8 Pages: 461-478 Pub: 2019 Aug Epub: Authors Dalile B , Van Oudenhove L , Vervliet B , Verbeke K , Publication Publication |
| arabinogalactan {arabinogalactan} - Roseburia |
👶
Lycium barbarum arabinogalactan alleviates intestinal mucosal damage in mice by restoring intestinal microbes and mucin O-glycans. Carbohydrate polymers (Carbohydr Polym ) Vol: 330 Issue Pages: 121882 Pub: 2024 Apr 15 Epub: 2024 Jan 28 Authors Zhao T , Liu S , Ma X , Shuai Y , He H , Guo T , Huang W , Wang Q , Liu S , Wang Z , Gong G , Huang L , Publication |
| arabinogalactan {arabinogalactan} - Roseburia |
👶
Arabinoxylans and inulin differentially modulate the mucosal and luminal gut microbiota and mucin-degradation in humanized rats. Environmental microbiology (Environ Microbiol ) Vol: 13 Issue 10 Pages: 2667-80 Pub: 2011 Oct Epub: 2011 Aug 30 Authors Van den Abbeele P , Gérard P , Rabot S , Bruneau A , El Aidy S , Derrien M , Kleerebezem M , Zoetendal EG , Smidt H , Verstraete W , Van de Wiele T , Possemiers S , Publication Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
